This is the authors' abstract. We don't add key points for this paper.
Presented here are two isostructural SOD-type zeolitic tetrazolate-imidazolate frameworks (ZTIFs), Zn(etz)0.86(mim)1.14 (ZTIF-9, Hetz = 5-ethyltetrazole, Hmim = 2-methylimidazole) and Zn(vtz)0.63(mim)1.37 (ZTIF-10, Hvtz = 5-vinyltetrazole). The adjustment of the ligand ratios within these ZTIFs was realized through changing the substituent groups of tetrazole ligands. Remarkably, ZTIF-9 with a suitable ligand ratio perfectly balances gas uptake and stability, exhibiting 6-fold improvement of C2H2 uptake compared to the prototype ZIF-8 (Zn(mim)2).
No takes yet. Share an insight, caveat, or question.
Li et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: